ISPE's Facility of the Year Award program celebrates the commitment and dedication of individuals working for different companies worldwide to enhance patient health and safety through innovation and advancements in pharmaceutical manufacturing technology. The award was established in 2004. ISPE is a not-for-profit organization serving members across the entire pharmaceutical lifecycle.

Sanofi's Framingham facility opened in October 2019 and was one of the first facilities using intensified, continuous biologics production technology. The facility is also paperless and data-driven, which enables Sanofi to achieve higher levels of productivity, agility, and flexibility. The facility launched its first commercially approved product in September 2020.

Sanofi, GSK begin clinical trial for COVID-19 vaccine
Sanofi and GlaxoSmithKline (GSK) have started the phase I/II clinical trial for an adjuvanted recombinant protein-based COVID-19 vaccine candidate.

Sanofi to acquire Principia Biopharma for $3.7B
Sanofi has announced that it plans to acquire Principia Biopharma for $3.7 billion.

Sanofi, GSK get $2.1B for COVID-19 vaccine
The U.S. government will provide up to $2.1 billion to Sanofi and GlaxoSmithKline (GSK) for the development and manufacturing of a recombinant protein-based...